Open AccessImpact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment – a real-life cohort study
Author(s) -
Andreas R. Gantenbein,
R. Agosti,
Claudio Gobbi,
Dominique Flügel,
Christoph Schankin,
Dragana Viceic,
Chiara Zecca,
Heiko Pohl
Publication year - 2021
Publication title -
cephalalgia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.57
H-Index - 125
eISSN - 1468-2982
pISSN - 0333-1024
DOI - 10.1177/03331024211014616
Subject(s) - medicine , discontinuation , migraine , calcitonin gene related peptide , calcitonin , cohort , antibody , incidence (geometry) , anesthesia , pediatrics , immunology , neuropeptide , physics , receptor , optics
This study aims to analyse the effect of the discontinuation of anti-calcitonin gene-related peptide antibodies on monthly migraine days after 12 treatment months.